BiotechTube

Taxol + TOCOSOL Paclitaxel

Phase 3Terminated
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Breast Neoplasm

Conditions

Breast Neoplasm

Trial Timeline

Sep 1, 2005 → Sep 1, 2007

NCT ID
NCT00251095

About Taxol + TOCOSOL Paclitaxel

Taxol + TOCOSOL Paclitaxel is a phase 3 stage product being developed by Achieve Life Sciences for Breast Neoplasm. The current trial status is terminated. This product is registered under clinical trial identifier NCT00251095. Target conditions include Breast Neoplasm.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00251095Phase 3Terminated

Competing Products

20 competing products in Breast Neoplasm

See all competitors
ProductCompanyStageHype Score
LymphoseekNavidea BiopharmaceuticalsPhase 3
69
LymphoseekNavidea BiopharmaceuticalsPhase 3
69
ALT-P7 (HM2-MMAE)AlteogenPhase 1
33
Biomarkers blood, urine and microbiota samplesEli LillyPre-clinical
23
gemcitabine + paclitaxel + bevacizumabEli LillyPhase 2
52
Gemcitabine + Adriamycine + PaclitaxelEli LillyPhase 2
52
Abemaciclib + FulvestrantEli LillyPhase 2
52
VS-6766 + Abemaciclib + FulvestrantEli LillyPhase 1/2
41
gemcitabine + vinorelbineEli LillyPhase 2
52
Abemaciclib + Fulvestrant + PlaceboEli LillyPhase 3
77
Azenosertib + Carboplatin + PembrolizumabZentalis PharmaceuticalsPhase 1/2
33
AbemaciclibEli LillyPre-clinical
23
pemetrexed + cyclophosphamide + doxorubicin + docetaxelEli LillyPhase 2
52
arzoxifeneEli LillyApproved
85
BBI-355 + Erlotinib + Futibatinib + BBI-825Boundless BioPhase 1
25
BBI-940 + FulvestrantBoundless BioPhase 1
25
LY4064809 + Placebo + Ribociclib + Palbociclib + Abemaciclib + Anastrozole + Letrozole + Exemestane + FulvestrantEli LillyPhase 3
77
pemetrexed + gemcitabineEli LillyPhase 2
52
Experimental Arm A: Pemetrexed + Experimental Arm A: Sorafenib + Experimental Arm B: Pemetrexed + Experimental Arm B: SorafenibEli LillyPhase 2
52
pemetrexedEli LillyPhase 2
52

Other Products from Achieve Life Sciences

Custirsen + Docetaxel + Prednisone + DexamethasonePhase 3
69
Custirsen + DocetaxelPhase 3
69
Cytisinicline + PlaceboPhase 3
69
Cytisinicline + PlaceboPhase 3
69
custirsen sodium + isotonic, 0.9% sodium chloride + docetaxel + cabazitaxel + prednisonePhase 3
69